Sleep as the Foundation of Longevity: HRV, REM, and What Your Wearable Misses

Of all the interventions in longevity-oriented medicine, sleep is the one with the largest evidence base, the highest leverage, and the lowest commercial profile. There is no patentable molecule in eight hours of consolidated rest. There is no compounded prescription for adequate REM. The economics of healthspan favour interventions that can be sold; sleep, which can only be earned, sits outside that economy.

That neglect is at odds with the data. Sleep duration and quality predict all-cause mortality, cardiovascular events, neurodegenerative risk, cancer incidence, and metabolic disease independent of nearly every other variable. Among the inputs a clinician can influence, sleep is the most consequential single variable. It is also the one most patients are getting wrong without realizing it.

What Sleep Actually Is

Sleep is not a single state. It is a structured progression through phases that serve different physiological purposes, repeating in roughly ninety-minute cycles across the night.

N1 and N2 (light sleep) are transitional and consolidating phases. Most of the night is spent here.

N3 (slow-wave sleep, often called deep sleep) is the phase during which growth hormone is released, glymphatic clearance of cerebral metabolic waste accelerates, and physical recovery is anchored. Deep sleep predominates in the first half of the night.

REM (rapid eye movement) sleep is the phase of vivid dreaming, emotional and memory consolidation, and active synaptic remodelling. REM density increases through the night, with the longest REM periods occurring in the final hours of sleep before waking.

A healthy adult cycles through all phases multiple times. A short, fragmented, or substance-distorted night truncates either deep sleep, REM, or both. The consequences differ depending on which phase is lost.

Insufficient deep sleep is associated with impaired physical recovery, growth hormone deficiency patterns, and elevated cortisol. Insufficient REM is associated with mood instability, impaired memory consolidation, and increased neurodegenerative risk over time. Chronically truncated sleep — whether through duration or fragmentation — is associated with insulin resistance, hypertension, increased inflammatory markers, and accelerated cellular aging signatures.

What Wearables Get Right and What They Miss

Consumer wearables — Oura, Whoop, Apple Watch, Garmin, others — have made sleep visible to a generation of patients in a way that polysomnography never could. The continuous data they produce is genuinely useful, with caveats.

What wearables do well. Sleep duration. Sleep timing and consistency. Resting heart rate trends. Heart rate variability (HRV) trends. Wake-after-sleep-onset estimates. Movement patterns. These metrics, particularly when tracked longitudinally over months, are clinically valuable. They identify trends that intermittent assessment cannot.

What wearables do less well. Sleep stage classification, especially the distinction between REM and light sleep, is approximate. Wrist-based and ring-based devices use heart rate variability, motion, and temperature to estimate stages — they do not measure brainwaves directly. The agreement with polysomnography for stage classification is imperfect, particularly for REM.

What wearables miss entirely. Sleep apnea screening through wearables is improving but cannot replace a formal sleep study when apnea is suspected. Periodic limb movements are not reliably captured. The presence of nocturnal hypoglycemia or hot flashes that fragment sleep without producing visible awakenings often goes undetected.

For most patients, the wearable data is a starting point. The pattern matters more than the absolute numbers. A drop in HRV that persists, a deep sleep percentage that has been declining for weeks, a temperature pattern that has shifted — these warrant clinical attention.

A more detailed look at how to interpret HRV and other wearable data appears in HRV, Resting Heart Rate, and What Your Wearable Is Telling You.

The Hormonal Cross-Talk

Sleep architecture and hormonal balance are recursive: each shapes the other.

Cortisol follows a diurnal rhythm with a peak shortly after waking and a nadir in the early hours of sleep. Disruption of this rhythm — through chronic stress, late-night light exposure, alcohol, or HPA-axis dysfunction — flattens the cortisol curve and fragments sleep. Patients who report waking at three a.m. consistently are often experiencing inappropriate cortisol elevation rather than insomnia in the conventional sense. The treatment is the underlying axis, not the symptom.

Progesterone has GABAergic activity and supports deep sleep. Declining progesterone in perimenopause is one of the most common and most under-recognized causes of sleep fragmentation in women in their thirties and forties. The pattern — falling asleep without difficulty but waking at one or two a.m. and being unable to settle back — is recognizable to anyone who has heard it described.

Estrogen influences thermoregulation. The hot flashes and night sweats of perimenopause and menopause produce micro-arousals throughout the night that fragment sleep architecture even when the patient does not consciously wake.

Testosterone is produced primarily during sleep, with peak release during REM. Sleep deprivation lowers next-day testosterone in men by clinically meaningful amounts. Conversely, sleep apnea is one of the most common reversible causes of low testosterone in men, and screening for it is essential before any TRT decision.

Thyroid function modulates sleep depth and recovery. Untreated subclinical hypothyroidism produces non-restorative sleep that wearables register as adequate duration but poor quality. The patient feels unrested despite seven or eight hours of sleep. The thyroid panel often clarifies what the sleep stage data alone cannot.

Growth hormone release during deep sleep is a major contributor to physical recovery and lean mass maintenance. Loss of deep sleep, whether due to age, alcohol, sleep apnea, or fragmentation, blunts this release.

The implication is that sleep dysfunction is rarely a sleep-only problem. It is most often a symptom of dysregulation elsewhere in the endocrine and metabolic system. Treating sleep without examining the hormonal landscape is treating the smoke without finding the fire.

What a Physician-Led Sleep Evaluation Includes

A serious sleep evaluation in a longevity-oriented practice extends well beyond “are you getting eight hours.”

It begins with a careful symptomatic history: onset, sleep latency, awakening pattern, daytime fatigue, refreshment on waking, snoring, witnessed apneas, restless legs, mood, and energy patterns through the day. It includes review of wearable data, particularly trends across weeks and months. It includes appropriate hormonal testing — full thyroid panel, sex hormones with attention to progesterone in symptomatic women, morning cortisol or salivary cortisol pattern when HPA-axis dysfunction is suspected — and metabolic panels because insulin resistance and sleep apnea coexist with high frequency.

It includes a low threshold for formal sleep study referral when obstructive or central sleep apnea is suspected. The diagnosis changes everything: untreated sleep apnea is associated with cardiovascular events, cognitive decline, and mortality at rates that no other intervention will offset.

The Vis Viva framework places sleep markers across all three domains. Sensus captures the lived experience of rest and recovery. Pulsus integrates the hormonal and inflammatory data that drive sleep quality. Virtus reflects the downstream consequence — exercise tolerance, recovery from training, body composition — that depends on consolidated nightly recovery.

What to Do Before Adding Anything

Before considering any sleep aid, supplement, or pharmacological intervention, the foundations matter more than any individual treatment.

Consistent sleep timing — bed and wake within a thirty-minute window, including on weekends — is the highest-leverage behavioural change for most patients. Light exposure in the morning and dimmer environments in the evening anchor the circadian rhythm. Reducing alcohol, particularly within three hours of bed, restores deep sleep. Avoiding caffeine after early afternoon shifts the curve. Cool, dark, quiet environments improve consolidation.

These are unglamorous interventions with disproportionate effects. Most patients who report poor sleep have not yet implemented them rigorously. When the foundations are in place and sleep remains poor, the conversation moves to hormonal evaluation, sleep study referral, and targeted clinical intervention.

The order matters. Reaching for melatonin or a sedative without examining the hormonal and behavioural foundations leaves the underlying disorder untreated and creates a dependence on the symptomatic fix.

Continue Reading

If you found this useful, these related articles may deepen your understanding:

• HRV, Resting Heart Rate, and What Your Wearable Is Telling You
• Why You Can’t Sleep Anymore: The Hormonal Explanation
• Cortisol, Adrenal Fatigue, and What’s Actually Happening

---

Dr. Handsun Xiao is a McGill trained physician (MD, CCFP) practicing functional medicine and bioidentical hormone therapy in Toronto, with virtual consultations available to patients across Ontario. He holds advanced BHRT certification through WorldLink Medical and IFM AFMCP training. Manus Solis offers physician led BHRT consultations with custom compounding through a dedicated Ontario compounding pharmacy partner Trutina. To learn more or book a virtual consultation, visit manussolis.ca.